No direct drug target

The classification No direct drug target refers to therapeutic agents that exert their effects through physicochemical mechanisms rather than by binding to a specific biological macromolecule such as a receptor, enzyme, or ion channel (ChEMBL, 2024). Instead of binding to receptors, these drugs rely on their inherent physicochemical properties to alter physiological environments (StatPearls, 2023). Common examples include antacids like Aluminum hydroxide, which neutralize stomach acid through simple chemical reactions, and osmotic diuretics like Mannitol, which shift fluid balance by creating concentration gradients (NCBI, 2022). Other agents, such as activated charcoal, work through physical adsorption to prevent the absorption of toxins in the gastrointestinal tract (PubMed, 2021). Because these agents lack a specific protein target, they are often excluded from traditional target-based drug discovery pipelines. Understanding this category is crucial for clinical pharmacology, as it encompasses a variety of essential treatments that operate outside the standard lock-and-key model of drug action. These drugs are typically characterized by high dose requirements and a lack of stereoselectivity compared to target-specific drugs.

Other names

Non-specific mechanism of actionNon-receptor mediated actionPhysicochemical drug actionNon-protein target

Drugs in this category function through non-specific physicochemical processes such as osmosis, chemical neutralization of acids, or physical adsorption rather than binding to a specific molecular receptor or enzyme (StatPearls, 2023; NCBI, 2022).